Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Co. stock logo
ATPC
Agape ATP
$1.29
+1.6%
$1.15
$0.90
$8.00
$5.15M2.311.55 million shs58,142 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$3.71
+1.6%
$3.86
$1.64
$6.30
$91.37M-0.0572,133 shs100,812 shs
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$1.47
+5.0%
$1.62
$1.08
$2.18
$67.59M1.24292,043 shs293,137 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$84.87
+0.3%
$88.05
$8.63
$115.60
$2.38B1.91645,811 shs615,336 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Co. stock logo
ATPC
Agape ATP
+1.57%+25.24%+29.00%+11.21%-79.78%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
+1.64%-3.64%-0.27%-19.87%+102.18%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
+5.00%-20.97%-10.37%-20.11%-8.13%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
+0.33%-12.00%-10.05%+6.58%+809.65%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Co. stock logo
ATPC
Agape ATP
0.5098 of 5 stars
0.04.00.00.02.50.00.0
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/AN/AN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/AN/AN/AN/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.3044 of 5 stars
1.33.00.00.03.24.21.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Co. stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.00
Strong BuyN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
4.00
Strong BuyN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.50
Moderate Buy$72.33-14.77% Downside

Current Analyst Ratings Breakdown

Latest ATPC, EUDA, WGS, and THTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/19/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $80.00
2/14/2025
Theratechnologies Inc. stock logo
THTX
Theratechnologies
Research Capitl
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
1/7/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$75.00 ➝ $118.00
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Co. stock logo
ATPC
Agape ATP
$1.35M3.80N/AN/A$1.14 per share1.13
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$3.81M23.97N/AN/A($0.30) per share-12.37
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$85.87M0.79N/AN/A($0.45) per share-3.27
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$305.45M7.80N/AN/A$8.78 per share9.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Co. stock logo
ATPC
Agape ATP
-$2.10M-$0.73N/AN/A-194.09%-74.71%-56.08%4/7/2025 (Estimated)
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$10.04MN/A0.00N/AN/AN/AN/AN/A5/6/2025 (Estimated)
Theratechnologies Inc. stock logo
THTX
Theratechnologies
-$23.96M-$0.18N/A21.00N/A-3.75%N/A-4.31%4/9/2025 (Estimated)
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$175.77M-$1.96N/A40.61N/A-17.12%3.33%1.69%5/5/2025 (Estimated)

Latest ATPC, EUDA, WGS, and THTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/31/2025Q4 2024
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.20N/A-$0.20N/A$0.36 million
2/18/2025Q4 2024
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.04$0.70+$0.66$0.23$82.24 million$95.64 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Co. stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Co. stock logo
ATPC
Agape ATP
0.05
3.59
3.53
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.13
N/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
1.08
0.97
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.25
2.40
2.27

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
0.01%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
9.67%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
27.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Co. stock logo
ATPC
Agape ATP
403.99 million3.60 millionNot Optionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
224.63 millionN/ANot Optionable
Theratechnologies Inc. stock logo
THTX
Theratechnologies
14045.98 millionN/AOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,20028.07 million19.97 millionOptionable

Recent News About These Companies

GeneDx management to meet virtually with Craig-Hallum

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.29 +0.02 (+1.57%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$1.27 -0.02 (-1.16%)
As of 06:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$3.71 +0.06 (+1.64%)
Closing price 04/2/2025 03:55 PM Eastern
Extended Trading
$3.74 +0.03 (+0.70%)
As of 04/2/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Theratechnologies stock logo

Theratechnologies NASDAQ:THTX

$1.47 +0.07 (+5.00%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$1.44 -0.03 (-1.77%)
As of 06:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

GeneDx stock logo

GeneDx NASDAQ:WGS

$84.87 +0.28 (+0.33%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$81.50 -3.38 (-3.98%)
As of 06:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.